Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
SNSE Sensei Biotherapeutics Inc
- Stocks
- Healthcare
- NASDAQ: SNSE
Price (delayed)
$0.3521
Market cap
$8.88M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.15
Enterprise value
$2.21M
Sensei Biotherapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company has developed
Highlights
SNSE's debt is down by 43% YoY and by 17% from the previous quarter
The net income has increased by 9% year-on-year and by 3.7% since the previous quarter
SNSE's equity is down by 45% YoY and by 17% from the previous quarter
The quick ratio is down by 44% YoY and by 13% from the previous quarter
Key stats
What are the main financial stats of SNSE
Market
Valuations
Earnings
Shares outstanding
25.21M
Market cap
$8.88M
Enterprise value
$2.21M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.28
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$31.16M
Net income
-$29.03M
EBIT
-$28.95M
EBITDA
-$26.33M
Free cash flow
-$24.22M
Per share
Balance sheet
Liquidity
EPS
-$1.15
EPS diluted
-$1.15
Free cash flow per share
-$0.96
Book value per share
$1.27
Revenue per share
$0
TBVPS
$1.52
Total assets
$38.27M
Total liabilities
$6.29M
Debt
$3.21M
Equity
$31.99M
Working capital
$30.45M
Debt to equity
0.1
Current ratio
6.82
Quick ratio
6.57
Net debt/EBITDA
0.25
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-59%
Return on equity
-69%
Return on invested capital
-82%
Return on capital employed
-87.6%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SNSE stock price
How has the Sensei Biotherapeutics stock price performed over time
Intraday
4.14%
1 week
19.36%
1 month
-17%
1 year
-47.71%
YTD
-28.16%
QTD
-10.63%
Financial performance
How have Sensei Biotherapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$31.16M
Net income
-$29.03M
Gross margin
N/A
Net margin
N/A
The operating income has grown by 10% YoY and by 4.5% from the previous quarter
The net income has increased by 9% year-on-year and by 3.7% since the previous quarter
Price vs fundamentals
How does SNSE's price correlate with its fundamentals
Growth
What is Sensei Biotherapeutics's growth rate over time
Valuation
What is Sensei Biotherapeutics stock price valuation
P/E
N/A
P/B
0.28
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
SNSE's EPS is up by 5% year-on-year and by 4.2% since the previous quarter
The price to book (P/B) is 65% lower than the 5-year quarterly average of 0.8 and 7% lower than the last 4 quarters average of 0.3
SNSE's equity is down by 45% YoY and by 17% from the previous quarter
Efficiency
How efficient is Sensei Biotherapeutics business performance
The ROIC has shrunk by 74% YoY and by 17% QoQ
SNSE's ROE is down by 48% YoY and by 11% from the previous quarter
The company's return on assets fell by 44% YoY and by 10% QoQ
Dividends
What is SNSE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SNSE.
Financial health
How did Sensei Biotherapeutics financials performed over time
The quick ratio is down by 44% YoY and by 13% from the previous quarter
Sensei Biotherapeutics's total assets has decreased by 43% YoY and by 16% from the previous quarter
SNSE's debt is 90% less than its equity
SNSE's equity is down by 45% YoY and by 17% from the previous quarter
SNSE's debt is down by 43% YoY and by 17% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.